Publications by authors named "Chengfeng Bi"

Claim this Profile
F
Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma.
Sunandini Sharma, Roshia Ali, Alyssa Bouska, Dylan Jochum, Meghana Kesireddy, Chengfeng Bi

Nat Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma-GATA3 molecular subgroup.
Waseem G Lone, Jiayu Yu, Xuxiang Liu, Dylan T Jochum, Alyssa Bouska, Chengfeng Bi, Jacob Robinson

Sci Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-grade B-cell lymphoma not otherwise specified, with diffuse large B-cell lymphoma gene expression signatures: Genomic analysis and potential therapeutics.
Waseem Lone, Alyssa Bouska, Tyler A Herek, Catalina Amador, Joo Song, Chengfeng Bi

Am J Hematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC overexpression in natural killer cell lymphoma: prognostic and therapeutic implications.
Chengfeng Bi, Yuhua Huang, Roshia Ali, Fang Wang, Xia Yang

Haematologica· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-17∼92 is involved in NF-κB activation via targeting the ubiquitin-editing proteins to mediate RIP1 complex polyubiquitinations in ABC-DLBCL.
Xiaoyan Zhang, Xuan Zhang, Xin Huang, Javeed Iqbal, Timothy W McKeithan, Chengfeng Bi

Clin Immunol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium.
Julie M Vose, Kai Fu, Lu Wang, Adnan Mansoor, Douglas Stewart, Chengfeng Bi

J Hematol Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OX40 shapes an inflamed tumor immune microenvironment and predicts response to immunochemotherapy in diffuse large B-cell lymphoma.
Yaxiao Lu, Yang Li, Jingwei Yu, Shen Meng, Chengfeng Bi, Bin Meng

Clin Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MCL1 as a therapeutic vulnerability in Burkitt lymphoma.
Ren Yuan, Michelle Y Wang, Chengfeng Bi, Xiaohong Zhao, Jianguo Tao

Leukemia· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Programmed Cell Death Protein 1/Programmed Cell Death Ligand-1 Axis activates Intracellular ERK Signaling in Tumor Cells to Mediate Poor Prognosis in T-cell Lymphoma.
Yang Li, Yue Fei, Lu Liu, Zheng Song, Xiangrui Meng, Chengfeng Bi, Bin Meng

J Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel MYC-non-IG fusion in refractory diffuse large B-cell lymphoma.
Cheng Wang, Pamela A Althof, Chengfeng Bi, Weiwei Zhang, Alyssa C Bouska

Br J Haematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting translation initiation by synthetic rocaglates for treating MYC-driven lymphomas.
Xuan Zhang, Chengfeng Bi, Ting Lu, Weiwei Zhang, Ting Yue

Leukemia· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57 and TP53INP1 in mantle cell lymphoma.
Wei Li, Chengfeng Bi, Yating Han, Tian Tian, Xianhuo Wang, Bin Meng

Cancer Biol Med· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The miR-17~92 cluster activates mTORC1 in mantle cell lymphoma by targeting multiple regulators in the STK11/AMPK/TSC/mTOR pathway.
Chunsun Jiang, Chengfeng Bi, Xiaoxing Jiang, Tian Tian, Xin Huang

Br J Haematol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models.
Xiaohong Zhao, Yuan Ren, Matthew Lawlor, Bijal D Shah, Paul M C Park, Chengfeng Bi

Cancer Cell· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas.
Yuan Ren, Chengfeng Bi, Xiaohong Zhao, Tint Lwin, Cheng Wang, Bijal D Shah, Bin Fang

J Clin Invest· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rac1 is a novel therapeutic target in mantle cell lymphoma.
Tian Tian, Chengfeng Bi, Ashley L Hein, Xuan Zhang, Cheng Wang

Blood Cancer J· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets.
Alyssa Bouska, Chengfeng Bi, Waseem Lone, Weiwei Zhang, Ambreen Kedwaii, Jan Delabie

Blood· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary central nervous system diffuse large B-cell lymphoma shows an activated B-cell-like phenotype with co-expression of C-MYC, BCL-2, and BCL-6.
Xiaomei Li, Ying Huang, Chengfeng Bi, Ji Yuan, Hong He

Pathol Res Pract· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of 4EBP phosphorylation mediates the cytotoxic effect of mechanistic target of rapamycin kinase inhibitors in aggressive B-cell lymphomas.
Chengfeng Bi, Xuan Zhang, Ting Lu, Xiaoyan Zhang, Xianhuo Wang, Bin Meng

Haematologica· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma.
Xiaohong Zhao, Tint Lwin, Ariosto Silva, Bijal Shah, Jiangchuan Tao, Bin Fang, Chengfeng Bi

Nat Commun· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
Javeed Iqbal, Hina Naushad, Chengfeng Bi, Jiayu Yu, Alyssa Bouska

Blood Rev· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP.
Xin Huang, Bin Meng, Javeed Iqbal, B Belinda Ding, Anamarija M Perry, Chengfeng Bi, Jan Delabie

J Clin Oncol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Diffuse large B-cell lymphoma of testis: a clinicopathologic and immunophenotypic study of 58 cases].
Zhi-rong Yang, Cheng-feng Bi, Wen-yan Zhang, Qun-pei Yang, Wei-ping Liu

Zhonghua Bing Li Xue Za Zhi· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low incidence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in Tianjin, northern China.
Yi Pan, Bin Meng, Huilai Zhang, Wenfeng Cao, Huaqing Wang, Chengfeng Bi

Leuk Lymphoma· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Analysis of the immunohistochemical subtypes and prognosis of primary diffuse large B cell lymphoma of the central nervous system].
Min Min, Li Lin, Cheng-Feng Bi, Xiao-Qing Wang, Tian-You Luo

Zhonghua Zhong Liu Za Zhi· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis